Literature DB >> 14004393

Histopathogenesis of carcinoma in situ of the uterine cervix.

P N WAHI, U KEHAR, S MALI, G D MISRA.   

Abstract

Cancer of the cervix is amenable to treatment provided it is diagnosed at the preinvasive stage, and it is therefore imperative to be able to identify cases of symptomless cervical cancer, which invariably presents no visible alteration in the appearance of the mucous membrane. Fortunately, this is possible by study of vaginal smears for exfoliated cells.In view of the ease with which carcinoma of the uterine cervix can be induced in mice and of its similarity to analogous lesions in women, it was thought that study of early cytological and morphological changes in cervical carcinoma of the mouse-especially at the in situ stage-might prove valuable for biological and therapeutic studies of human cervical carcinoma.This paper reports on study of the progressive epithelial changes in the mouse cervix by means of exfoliated cells in vaginal smears and histological examination of the cervical epithelium after intravaginal painting with 3,4-benzpyrene. The authors consider that basal cell hyperplasia and the early grades of dysplasia are reversible if the carcinogenic agent is withdrawn, but that the lesion is likely to be invasive and progressive once the presence of large numbers of squamoid cells indicates that the dysplastic changes involve the superficial layers.

Entities:  

Keywords:  CARCINOMA, EPIDERMOID/experimental; CERVIX NEOPLASMS/experimental

Mesh:

Year:  1962        PMID: 14004393      PMCID: PMC2555775     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  11 in total

1.  The so-called perinuclear halo.

Authors:  E DE GIROLAMI
Journal:  Obstet Gynecol       Date:  1961-02       Impact factor: 7.661

2.  Experimental carcinoma of the uterine cervix.

Authors:  D G SCARPELLI
Journal:  Prog Exp Tumor Res       Date:  1960

3.  The nature of the perinuclear halo: further clinical, cytological, and pathological studies.

Authors:  N SAGIROGLU
Journal:  Am J Obstet Gynecol       Date:  1959-01       Impact factor: 8.661

4.  Experimental carcinoma of the uterine cervix in the mouse; a gross and histopathologic study.

Authors:  D G SCARPELLI; E VON HAAM
Journal:  Am J Pathol       Date:  1957 Nov-Dec       Impact factor: 4.307

5.  The cellular pathology in carcinoma in situ; a cytohistopathological correlation.

Authors:  J W REAGAN; M J HAMONIC
Journal:  Cancer       Date:  1956 Mar-Apr       Impact factor: 6.860

6.  Induced cancer of the cervix uteri in the mouse.

Authors:  J W REAGAN; W B WENTZ; N MACHICAO
Journal:  AMA Arch Pathol       Date:  1955-10

7.  The cellular morphology of carcinoma in situ and dysplasia or atypical hyperplasia of the uterine cervix.

Authors:  J W REAGAN; I L SEIDEMANN; Y SARACUSA
Journal:  Cancer       Date:  1953-03       Impact factor: 6.860

8.  Exfoliative dyskaryotic cells associated with atypical cervical lesions.

Authors:  L S LAPID; M A GOLDBERGER
Journal:  Am J Obstet Gynecol       Date:  1951-06       Impact factor: 8.661

9.  Exfoliative cytology in diagnosis of cancer.

Authors:  P N WAHI; R L JAIN
Journal:  J Indian Med Assoc       Date:  1950-09

10.  The vaginal smear; precancer cell studies using a modified technique.

Authors:  J E AYRE
Journal:  Am J Obstet Gynecol       Date:  1949-12       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.